Given the connection between monocytic AML and BCL2 inhibitor resistance, we set out to determine if the co-expression of AHR and HLA-E could discriminate BCL2 family expression as well as expression of an immune repertoire. This evidence concerns the gene HLA-E and acute myeloid leukemia.